Secretin as a neuropeptide

Molecular Neurobiology

Volumn 26, Issue 1, 2002, Pages 97-107

  Ng, S S M ^a,b   Yung, W H ^b   Chow, B K C ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Autism; Cerebellum; GABA; Inhibitory postsynaptic currents; Neuropeptide; Purkinje cells; Secretin

Indexed keywords

NEUROPEPTIDE; NEUROPEPTIDE RECEPTOR; SECRETIN;

BRAIN CORTEX; BRAIN FUNCTION; CELL POPULATION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; CEREBELLUM; ELECTROPHYSIOLOGY; GABAERGIC TRANSMISSION; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOTOR PERFORMANCE; NERVE CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; RODENT;

EID: 0036700151     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/mn:26:1:097     Document Type: Review

References (77)

1. Bayliss W. M. and Starling E. H. (1902) The mechanism of pancreatic secretion. J. Physiol. (Lond) 28, 325-353.
2. Bayliss W. M. and Starling E. H. (1904) Croonian Lecture. The chemical regulation of the secretory process. Proc. R. Soc. Lond. [Biol.] 73, 310-332.
3. Starling E. (1905) The Croonian Lectures on the chemical correlation of the function of the body. Lancet 2, 339-341.
4. Bayliss W. M. (1920) Principles of General Physiology, 3rd ed., Longmans Green, London.
5. Jorpes J. E. and Mutt V. (1961) On the biological activity and amino acid composition of secretin. Acta. Chem. Scand. 151, 1790-1791.
6. Mutt V., Jorpes J. E., and Magnusson S. (1970) Structure of porcine secretin: the amino acid sequence. Eur. J. Biochem. 15, 513-519.
7. Gafvelin G., Carlquist M., and Mutt V. (1985) A proform of secretin: with high secretin-like bioactivity. FEBS Lett. 184, 347-352.
8. Gafvelin G., Jornvall H., and Mutt V. (1990) Processing of prosecretin: isolation of a secretin precursor from porcine intestine. Proc. Natl. Acad. Sci. USA 87, 6781-6785.
9. Nilsson A., Carlquist M., Jornvall H., and Mutt V. (1980) Isolation and characterization of chicken secretin. Eur. J. Biochem. 112, 383-388.
10. Carlquist M., Jornvall H., and Mutt V. (1981) Isolation and amino acid sequence of bovine secretin. FEBS Lett. 127, 71-74.
11. Carlquist M., Jornvall H., Forssmann W. G., Thulin L., Johansson C., and Mutt V. (1985) Human secretin is not identical to the porcine/bovine hormone. IRCS J. Med. Sci. 13, 217-218.
12. Shinomura Y., Eng J., and Yalow R. S. (1987) Dog secretin: sequence and biological activity. Life Sci. 41, 1243-1248.
13. Gossen D., Vandermeers A., Vandermeers-Piret M. C., Rathe J., Cauvin A., Robberecht P., and Christophe J. (1989) Isolation and primary structure of rat secretin. Biochem. Biophys. Res. Commun. 160, 862-867.
14. Vaudry D., Gonzalez B. J., Basille M., Yon L., Fournier A., and Vaudry H. (2000) Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions. Pharmacol. Rev. 52, 269-324.
15. Meyer J. H., Way L. W., and Grossman M. I. (1970) Pancreatic response to acidification of various lengths of proximal intestine in the dog. Am. J. Physiol. 219, 971-977.
16. Watanabe S., Chey W. Y., Lee K. Y., and Chang T. M. (1986) Secretin is released by digestive products of fat in dogs. Gastroenterology 90, 1008-1017.
17. Allen A., Hutton D. A., Leonard A. J., and Pearson J. P. (1986) The role of mucus in the protection of the gastroduodenal mucosa. Scand. J. Gastroenterol. 21, 71-77.
18. Rausch U., Vaisoloudes P., Rudiger K., and Kern H. F. (1985) In-vivo stimulation of rat pancreatic acinar cells by infusion of secretin. II. Changes in individual rates of enzyme and isoenzyme biosynthesis. Cell Tissue Res. 242, 633-639.
19. Johnson L. R. (1976) The trophic action of gastrointestinal hormones. Gastroenterology 70, 278-288.
20. Solomon T. E., Peterson H., Elashoff J., and Grossman M. I. (1978) Interaction of caerulein and secretin on pancreatic size and composition in rat. Am. J. Physiol. 235, 714-719.
21. Dembinski A. B. and Johnson L. R. (1980) Stimulation of pancreatic growth by secretin, caerulein, and pentagastrin. Endocrinology 21, 589-597.
22. Valenzuela J. E. and Defilippi C. (1981) Inhibition of gastric emptying in humans by secretion, the octapeptide of cholecystokinin, and intraduodenal fat. Gastroenterology 81, 898-902.
23. Kleibeuker J. H., Eysselein V. E., Maxwell V. E., and Walsh J. H. (1984) Role of endogenous secretin in acid-induced inhibition of human gastric function. J. Clin. Invest. 73, 526-532.
24. You C. H. and Chey W. Y. (1987) Secretion is an enterogastrone in humans. Dig. Disc. Sci. 32, 466-471.
25. Raybould H. E. and Holzer H. H. (1993) Duodenal acid-induced inhibition of gastric motility and emptying in rats. Am. J. Physiol. 265, G540-546.
26. Jin H. O., Lee K. Y., Chang T. M., Chey W. Y., and Dubois A. (1994) Secretin, a physiological regulator of gastric emptying acid output in dogs. Am. J. Physiol. 30, G702-708.
27. - channels in bile duct epithelial cells through a cAMP-dependent mechanism. Am. J. Physiol. 266, G731-736.
28. Olsen P. S., Kirkegaard P., Ponlsen S. S., and Nexo E. (1994) Effect of secretin and somatostatin on secretion of epidermal growth factor from Brunner's gland in the rat. Dig. Dis. Sci. 39, 2186-2190.
29. Charlton C. G., Quirion R., Handelmann G. E., Miller R. L., Jensen R. T., Finkel M. S., and O'Donohue T. L. (1986) Secretin receptors in the rat kidney: adenylate cyclase activation and renal effects. Peptides 7, 865-871.
30. Bell D. and McDermott B. J. (1994) Secretin and VIP are potent stimulants of cellular contraction and accumulation of cAMP in rat ventricular cardiomyocytes. J. Cardiovasc. Pharmacol. 23, 959-969.
31. Horvath K., Stefanatos G., Sokolski K. N., Wachtel R., Nabors L., and Tildon J. T. (1998) Improved social and language skills after secretin administration in patients with autistic spectrum disorders. J. Assoc. Acad. Minor. Phys. 9, 9-15.
32. Lamson D. W. and Plaza S. M. (2001) Transdermal secretin for autism: a case report. Altern. Med. Rev. 6, 311-313.
33. Sandler A. D., Sutton K. A., DeWeese J., Girardi M. A., Sheppard V., and Bodfish J. W. (1999) Lack of benefit of a single dose of synthetic human secretin in the treatment of autism and pervasive developmental disorder. N. Engl. J. Med. 341, 1801-1806.
34. Chez M. G., Buchanan C. P., Bagan B. T., Hammer M. S., McCarthy K. S., Ovrutskaya I., et al. (2000) Secretin and autism: a two-part clinical investigation. J. Autism Dev. Disord. 30, 87-94.
35. Dunn-Geier J., Ho H. H., Auersperg E., Doyle D., Eaves L., Matsuba C., et al, (2000) Effect of secretin on children with autism: a randomized controlled trial. Dev. Med. Child. Neurol. 42, 796-802.
36. Coniglio S. J., Lewis J. D., Lang C., Burns T. G., Subhani-Siddique R., Weintraub A., et al. (2001) A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism. J. Pediatr. 138, 649-655.
37. Corbett B., Khan K., Czapansky-Beilman D., Brady N., Dropik P., Goldman D. Z., et al. (2001) A double-blind, placebo-controlled crossover study investigating the effect of porcine secretion in children with autism. Clin. Pediatr. (Phila.) 40, 327-331.
38. Lightdale J. R., Hayer C., Duer A., Lind-White C., Jenkins S., Siegel B., et al. (2001) Effects of intravenous secretin on language and behavior of children with autism and gastrointestinal symptoms: a single-blinded, open-label pilot study. Pediatrics 108, E90.
39. Owley T., McMahon W., Cook E. H., Laulhere T., South M., Mays L. Z., et al. (2001) Multisite, double-blind, placebo-controlled trial of porcine secretin in autism. J. Am. Acad. Child. Adolesc. Psychiatry 40, 1293-1299.
40. Roberts W., Weaver L., Brian J., Bryson S., Emelianova S., Griffiths A. M., et al. (2001) Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial. Pediatrics 107, E71.
41. Babu G. N. and Vijayan E. (1983) Plasama gonadotropin, prolactin levels and hypothalamic tyrosine hydroxylase activity following intraventricular bombesin and secretin in ovariectomized conscious rats. Brain Res. Bull. 11, 25-29.
42. Fuxe K., Andersson K., Hokfelt T., Mutt V., Ferland L., Agnati L. F., et al. (1979) Localization and possible function of peptidergic neurons and their interactions with central catecholamine neurons, and the central actions of gut hormones. Fed. Proc. 38, 2333-2340.
43. Charlton C. G., Miller R. L., Crawley J. N., Handelmann G. E., and O'Donohue T. L. (1983) Secretin modulation of behavioral and physiological functions in the rat. Peptides 4, 739-742.
44. Samson W. K., Lumpkin M. D., and McCann S. M. (1984) Presence and possible site of action of secretin in the rat pituitary and hypothalamus. Life Sci. 34, 155-163.
45. Ip N. Y., Ho C. K., and Zigmond R. E. (1982) Secretin and vasoactive intestinal peptide acutely increase tyrosine 3-monooxygenase in the rat superior cervical ganglion. Proc. Natl. Acad. Sci. USA 79, 7566-7569.
46. Wessels-Reiker M., Basibonia R., Howlett A. C., and Strong R. (1993) Vasoactive intestinal polypeptide-related peptides modualte tyrosine hydroxylase gene expression in PC12 cells through multiple adenylate cyclase-coupled receptors. J. Neurochem. 60, 1018-1029.
47. Fremeau R. T. Jr., Korman L. Y., and Moody T. W. (1986) Secretin stimualtes cyclic AMP formation in the rat brain. J. Neurochem. 46, 1947-1955.
48. van Calker D., Muller M., and Hamprecht B. (1980) Regulation by secretin, vasoactive intestinal peptide, and somatostatin of cyclic AMP accumulation in cultured brain cells. Proc. Natl. Acad. Sci. USA 77, 6907-6911.
49. Propst F., Moroder L., Wunsch E., and Hamprecht B. (1979) The influence of secretin, glucagon and other peptides, of amino acids, prostaglandin endoperoxide analogues and diazepam on the level of adenosine 3′,5′-cyclic monophosphate in neuroblastoma x glioma hybrid cells. J. Neurochem. 32, 1495-1500.
50. Bodfish J. W., Symons F. J., Parker D. E., and Lewis M. H. (2000) Varieties of repetitive behavior in autism: comparisons to mental retardation. J. Autism Dev. Disord. 30, 237-243.
51. Horvath K., Papadimitriou J. C., Rabsztyn A., Drachenberg C., and Tildon J. T. (1999) Gastrointestinal abnormalities in children with autistic disorder. J. Pediatr. 135, 559-563.
52. Taira M., Takase M., and Sasaki H. (1998) Sleep disorder in children with autism. Psychiatry Clin. Neurosci. 52, 182-183.
53. Hering E., Epstein R., Elroy S., Iancu D. R., and Zelnik N. (1999) Sleep patterns in autistic children. J. Autism Dev. Disord. 29, 143-147.
54. Lord C., Cook E. H., Leventhal B. L., and Amaral D. G. (2000) Autims spectrum disorders. Neuron 28, 355-363.
55. Itoh K., Furuya T., Ozaki K., Ohta M., and Kawasaki T. (1991) The secretin precursor gene. Proc. Natl. Acad. Sci. USA 266, 12595-12598.
56. Kopin A. S., Wheeler M. B., Nishitani J., Mcbride E. W., Chang T. M., Chey W. Y., and Leiter A. B. (1991) The secretin gene: evolutionary history, alternative splicing, and developmental regulation. Proc. Natl. Acad. Sci. USA 88, 5335-5339.
57. Kopin A. S., Wheeler M. B., and Leiter A. B. (1990) Secretin: structure of the precursor and tissue distribution of the mRNA. Proc. Natl. Acad. Sci. USA 87, 2299-2303.
58. Ishihara T., Nakamura S., Kaziro Y., Takahashi T., Takahashi K., and Nagata S. (1991) Molecular cloning and expression of a cDNA encoding the secretin receptor. EMBO J. 10, 1635-1641.
59. O'Donohue T. L., Charlton C. G., Miller R. L., Boden G., and Jacobowitz D. M. (1981) Identification, characterization, and distribution of secretin immunoreactivity in rat and pig brain. Proc. Natl. Acad. Sci. USA 78, 5221-5224.
60. Mutt V., Carlquist M., and Tatemoto K. (1979) Secretin-like bioactivity in extracts of porcine brain. Life Sci. 25, 1703-1707.
61. Whitmore T. E., Holloway J. L., Lofton-Day C. E., Maurer M. F., Chen L., Ouinton T. J., et al. (2000) Human secretin (SCT): gene structure, chromosome location, and distribution of mRNA. Cytogenet. Cell Genet. 90, 47-52.
62. Fremeau R. T. Jr., Jensen R. T., Charlton C. G., Miller R. L., O'Donohue T. L., and Moody T. W. (1983) Secretin: specific binding to the rat brain membranes. J. Neurosci. 3, 1620-1625.
63. Chow B. K. C. (1995) Molecular cloning and functional characterization of a human secretin receptor. Biochem. Biophys. Res. Commun. 212, 204-211.
64. Conter R. L., Hughes M. T., and Kauffman G. L. Jr. (1996) Intracerebroventricular secretin enhances pancreatic volume and bicarbonate response in rats. Surgery 119, 208-213.
65. Banks W. A., Goulet M., Boismenu R., and Rusche J. (2001) Secretin infusions cross from blood to brain compartments in mice. 31st Annual Meeting of Society for Neuroscience, San Diego, CA, Abstract # 239.10.
66. Goulet M., Blais V., Shiromani P., Boismenu R., Rusche J., and Rivest S. (2001) Activation of the rat central nervous system by intravenous secretin infusion. 31st Annual Meeting of Society for Neuroscience, San Diego, CA, Abstract # 90.18.
67. Yung W. H., Leung P. S., Ng S. S. M., Zhang J., Chan S. C. Y., and Chow B. K. C. (2001) Secretin facilitates GABA transmission in the cerebellum. J. Neurosci. 21, 7063-7068.
68. Vaudry D., Gonzalez B. J., Basille M., Fournier A., Vaudry H. (1999) Neurotrophic activity of pituitary adenylate cyclase-activating polypeptide on rat cerebellar cortex during development. Proc. Natl. Acad. Sci. USA 96, 9415-9420.
69. Vaudry D., Gonzalez B. J., Basille M., Pamantung T. F., Fontaine M., Fournier A., Vaudry H. (2000) The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32. Proc. Natl. Acad. Sci. USA 97, 13390-13395.
70. Altman J. and Bayer S. A. (1997) Development of the Cerebellar System: in Relation to its Evolution, Structure, and Functions. CRC Press, Boca Raton, FL.
71. Marty A. and Llano I. (1995) Modulation of inhibitory synapses in the mammalian brain. Curr. Opin. Neurobiol. 5, 335-341.
72. Kano M., Rexhausen U., Dressen J., and Konnerth A. (1992) Synaptic excitation produces a long-lasting rebound potentiation of inhibitory synaptic signals in cerebellar Purkinje cells. Nature 356, 601-604.
73. Bailey A., Le Couteur A., Gottesman I., Bolton P., Simonoff E., Yuzda E., and Rutter M. (1995) Autism as a strongly genetic disorder: evidence from a British twin study. Psychol. Med. 25, 63-77.
74. Andres C. (2002) Molecular genetics and animal models in autistic disorder. Brain Res. Bull. 57, 109-119.
75. International Molecular Genetic Study of Autism Consortium (IMGSAC) (2001) A genomewide screen for autism: strong evidence for linkage to chromosomes 2q, 7q, and 16p. Am. J. Hum. Genet. 69, 570-581.
76. Whitmore T. E., Holloway I. L., Lofton-Day C. E., Maurer M. E., Chen L., Quinton T. J., et al. (2000) Human secretin (SCT): gene structure, chromosome location, and distribution of mRNA. Cytogenet. Cell. Genet. 90, 47-52.
77. Mark H. F. and Chow B. K. C. (1995) Localization of the gene encoding the secretin receptor, SCTR, on human chromosome 2q14.1 by fluorescence in situ hybridization and chromosome morphometry. Genomics 29, 817-818.